Hmdb loader
Record Information
Version5.0
StatusDetected but not Quantified
Creation Date2012-09-06 21:03:49 UTC
Update Date2021-09-14 15:46:18 UTC
HMDB IDHMDB0029133
Secondary Accession Numbers
  • HMDB29133
Metabolite Identification
Common NameValylmethionine
DescriptionValylmethionine is a dipeptide composed of valine and methionine. It is an incomplete breakdown product of protein digestion or protein catabolism. Dipeptides are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Some dipeptides are known to have physiological or cell-signalling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.
Structure
Data?1582753380
Synonyms
ValueSource
L-Val-L-metChEBI
Valyl-methionineChEBI
VMChEBI
L-Valyl-L-methionineHMDB
N-L-Valyl-L-methionineHMDB
N-ValylmethionineHMDB
V-m DipeptideHMDB
VM DipeptideHMDB
Val-metHMDB
Valine methionine dipeptideHMDB
Valine-methionine dipeptideHMDB
ValylmethionineChEBI
Chemical FormulaC10H20N2O3S
Average Molecular Weight248.34
Monoisotopic Molecular Weight248.119463686
IUPAC Name(2S)-2-[(2S)-2-amino-3-methylbutanamido]-4-(methylsulfanyl)butanoic acid
Traditional Name(2S)-2-[(2S)-2-amino-3-methylbutanamido]-4-(methylsulfanyl)butanoic acid
CAS Registry Number14486-09-0
SMILES
CSCC[C@H](NC(=O)[C@@H](N)C(C)C)C(O)=O
InChI Identifier
InChI=1S/C10H20N2O3S/c1-6(2)8(11)9(13)12-7(10(14)15)4-5-16-3/h6-8H,4-5,11H2,1-3H3,(H,12,13)(H,14,15)/t7-,8-/m0/s1
InChI KeyYSGSDAIMSCVPHG-YUMQZZPRSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as dipeptides. These are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond.
KingdomOrganic compounds
Super ClassOrganic acids and derivatives
ClassCarboxylic acids and derivatives
Sub ClassAmino acids, peptides, and analogues
Direct ParentDipeptides
Alternative Parents
Substituents
  • Alpha-dipeptide
  • Phenylalanine or derivatives
  • N-acyl-alpha-amino acid
  • N-acyl-alpha amino acid or derivatives
  • N-acyl-l-alpha-amino acid
  • Valine or derivatives
  • Alpha-amino acid amide
  • 3-phenylpropanoic-acid
  • Amphetamine or derivatives
  • Alpha-amino acid or derivatives
  • Monocyclic benzene moiety
  • Fatty acyl
  • Benzenoid
  • N-acyl-amine
  • Fatty amide
  • Carboxamide group
  • Carboxylic acid salt
  • Secondary carboxylic acid amide
  • Amino acid or derivatives
  • Amino acid
  • Carboxylic acid
  • Monocarboxylic acid or derivatives
  • Organic nitrogen compound
  • Organonitrogen compound
  • Primary aliphatic amine
  • Organooxygen compound
  • Primary amine
  • Organic zwitterion
  • Organic salt
  • Carbonyl group
  • Hydrocarbon derivative
  • Organic oxide
  • Organopnictogen compound
  • Amine
  • Organic oxygen compound
  • Aromatic homomonocyclic compound
Molecular FrameworkAromatic homomonocyclic compounds
External Descriptors
Ontology
Physiological effectNot Available
Disposition
ProcessNot Available
RoleNot Available
Physical Properties
StateSolid
Experimental Molecular Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogP-1.84Extrapolated
Experimental Chromatographic PropertiesNot Available
Predicted Molecular Properties
PropertyValueSource
Water Solubility2.88 g/LALOGPS
logP-0.93ALOGPS
logP-1.8ChemAxon
logS-1.9ALOGPS
pKa (Strongest Acidic)3.93ChemAxon
pKa (Strongest Basic)8.51ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count4ChemAxon
Hydrogen Donor Count3ChemAxon
Polar Surface Area92.42 ŲChemAxon
Rotatable Bond Count7ChemAxon
Refractivity63.88 m³·mol⁻¹ChemAxon
Polarizability26.4 ųChemAxon
Number of Rings0ChemAxon
BioavailabilityYesChemAxon
Rule of FiveYesChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted Chromatographic Properties

Predicted Collision Cross Sections

PredictorAdduct TypeCCS Value (Å2)Reference
DeepCCS[M+H]+163.00330932474
DeepCCS[M-H]-160.64530932474
DeepCCS[M-2H]-193.53130932474
DeepCCS[M+Na]+169.09630932474

Predicted Kovats Retention Indices

Underivatized

MetaboliteSMILESKovats RI ValueColumn TypeReference
ValylmethionineCSCC[C@H](NC(=O)[C@@H](N)C(C)C)C(O)=O3034.7Standard polar33892256
ValylmethionineCSCC[C@H](NC(=O)[C@@H](N)C(C)C)C(O)=O1995.2Standard non polar33892256
ValylmethionineCSCC[C@H](NC(=O)[C@@H](N)C(C)C)C(O)=O2057.2Semi standard non polar33892256

Derivatized

Derivative Name / StructureSMILESKovats RI ValueColumn TypeReference
Valylmethionine,1TMS,isomer #1CSCC[C@H](NC(=O)[C@@H](N)C(C)C)C(=O)O[Si](C)(C)C2026.6Semi standard non polar33892256
Valylmethionine,1TMS,isomer #2CSCC[C@H](NC(=O)[C@@H](N[Si](C)(C)C)C(C)C)C(=O)O2047.9Semi standard non polar33892256
Valylmethionine,1TMS,isomer #3CSCC[C@@H](C(=O)O)N(C(=O)[C@@H](N)C(C)C)[Si](C)(C)C1995.3Semi standard non polar33892256
Valylmethionine,2TMS,isomer #1CSCC[C@H](NC(=O)[C@@H](N[Si](C)(C)C)C(C)C)C(=O)O[Si](C)(C)C2098.0Semi standard non polar33892256
Valylmethionine,2TMS,isomer #1CSCC[C@H](NC(=O)[C@@H](N[Si](C)(C)C)C(C)C)C(=O)O[Si](C)(C)C2035.0Standard non polar33892256
Valylmethionine,2TMS,isomer #2CSCC[C@@H](C(=O)O[Si](C)(C)C)N(C(=O)[C@@H](N)C(C)C)[Si](C)(C)C1993.7Semi standard non polar33892256
Valylmethionine,2TMS,isomer #2CSCC[C@@H](C(=O)O[Si](C)(C)C)N(C(=O)[C@@H](N)C(C)C)[Si](C)(C)C2071.6Standard non polar33892256
Valylmethionine,2TMS,isomer #3CSCC[C@@H](C(=O)O)N(C(=O)[C@@H](N[Si](C)(C)C)C(C)C)[Si](C)(C)C2038.9Semi standard non polar33892256
Valylmethionine,2TMS,isomer #3CSCC[C@@H](C(=O)O)N(C(=O)[C@@H](N[Si](C)(C)C)C(C)C)[Si](C)(C)C2051.0Standard non polar33892256
Valylmethionine,2TMS,isomer #4CSCC[C@H](NC(=O)[C@H](C(C)C)N([Si](C)(C)C)[Si](C)(C)C)C(=O)O2193.5Semi standard non polar33892256
Valylmethionine,2TMS,isomer #4CSCC[C@H](NC(=O)[C@H](C(C)C)N([Si](C)(C)C)[Si](C)(C)C)C(=O)O2105.9Standard non polar33892256
Valylmethionine,3TMS,isomer #1CSCC[C@@H](C(=O)O[Si](C)(C)C)N(C(=O)[C@@H](N[Si](C)(C)C)C(C)C)[Si](C)(C)C2038.3Semi standard non polar33892256
Valylmethionine,3TMS,isomer #1CSCC[C@@H](C(=O)O[Si](C)(C)C)N(C(=O)[C@@H](N[Si](C)(C)C)C(C)C)[Si](C)(C)C2106.8Standard non polar33892256
Valylmethionine,3TMS,isomer #2CSCC[C@H](NC(=O)[C@H](C(C)C)N([Si](C)(C)C)[Si](C)(C)C)C(=O)O[Si](C)(C)C2188.6Semi standard non polar33892256
Valylmethionine,3TMS,isomer #2CSCC[C@H](NC(=O)[C@H](C(C)C)N([Si](C)(C)C)[Si](C)(C)C)C(=O)O[Si](C)(C)C2181.0Standard non polar33892256
Valylmethionine,3TMS,isomer #3CSCC[C@@H](C(=O)O)N(C(=O)[C@H](C(C)C)N([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C2190.8Semi standard non polar33892256
Valylmethionine,3TMS,isomer #3CSCC[C@@H](C(=O)O)N(C(=O)[C@H](C(C)C)N([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C2211.8Standard non polar33892256
Valylmethionine,4TMS,isomer #1CSCC[C@@H](C(=O)O[Si](C)(C)C)N(C(=O)[C@H](C(C)C)N([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C2232.4Semi standard non polar33892256
Valylmethionine,4TMS,isomer #1CSCC[C@@H](C(=O)O[Si](C)(C)C)N(C(=O)[C@H](C(C)C)N([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C2273.0Standard non polar33892256
Valylmethionine,1TBDMS,isomer #1CSCC[C@H](NC(=O)[C@@H](N)C(C)C)C(=O)O[Si](C)(C)C(C)(C)C2269.5Semi standard non polar33892256
Valylmethionine,1TBDMS,isomer #2CSCC[C@H](NC(=O)[C@@H](N[Si](C)(C)C(C)(C)C)C(C)C)C(=O)O2288.2Semi standard non polar33892256
Valylmethionine,1TBDMS,isomer #3CSCC[C@@H](C(=O)O)N(C(=O)[C@@H](N)C(C)C)[Si](C)(C)C(C)(C)C2227.8Semi standard non polar33892256
Valylmethionine,2TBDMS,isomer #1CSCC[C@H](NC(=O)[C@@H](N[Si](C)(C)C(C)(C)C)C(C)C)C(=O)O[Si](C)(C)C(C)(C)C2538.5Semi standard non polar33892256
Valylmethionine,2TBDMS,isomer #1CSCC[C@H](NC(=O)[C@@H](N[Si](C)(C)C(C)(C)C)C(C)C)C(=O)O[Si](C)(C)C(C)(C)C2457.7Standard non polar33892256
Valylmethionine,2TBDMS,isomer #2CSCC[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)N(C(=O)[C@@H](N)C(C)C)[Si](C)(C)C(C)(C)C2457.6Semi standard non polar33892256
Valylmethionine,2TBDMS,isomer #2CSCC[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)N(C(=O)[C@@H](N)C(C)C)[Si](C)(C)C(C)(C)C2491.7Standard non polar33892256
Valylmethionine,2TBDMS,isomer #3CSCC[C@@H](C(=O)O)N(C(=O)[C@@H](N[Si](C)(C)C(C)(C)C)C(C)C)[Si](C)(C)C(C)(C)C2512.4Semi standard non polar33892256
Valylmethionine,2TBDMS,isomer #3CSCC[C@@H](C(=O)O)N(C(=O)[C@@H](N[Si](C)(C)C(C)(C)C)C(C)C)[Si](C)(C)C(C)(C)C2445.4Standard non polar33892256
Valylmethionine,2TBDMS,isomer #4CSCC[C@H](NC(=O)[C@H](C(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(=O)O2661.8Semi standard non polar33892256
Valylmethionine,2TBDMS,isomer #4CSCC[C@H](NC(=O)[C@H](C(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(=O)O2504.0Standard non polar33892256
Valylmethionine,3TBDMS,isomer #1CSCC[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)N(C(=O)[C@@H](N[Si](C)(C)C(C)(C)C)C(C)C)[Si](C)(C)C(C)(C)C2740.7Semi standard non polar33892256
Valylmethionine,3TBDMS,isomer #1CSCC[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)N(C(=O)[C@@H](N[Si](C)(C)C(C)(C)C)C(C)C)[Si](C)(C)C(C)(C)C2670.4Standard non polar33892256
Valylmethionine,3TBDMS,isomer #2CSCC[C@H](NC(=O)[C@H](C(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C2901.1Semi standard non polar33892256
Valylmethionine,3TBDMS,isomer #2CSCC[C@H](NC(=O)[C@H](C(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C2732.5Standard non polar33892256
Valylmethionine,3TBDMS,isomer #3CSCC[C@@H](C(=O)O)N(C(=O)[C@H](C(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C2868.4Semi standard non polar33892256
Valylmethionine,3TBDMS,isomer #3CSCC[C@@H](C(=O)O)N(C(=O)[C@H](C(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C2749.3Standard non polar33892256
Valylmethionine,4TBDMS,isomer #1CSCC[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)N(C(=O)[C@H](C(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C3109.2Semi standard non polar33892256
Valylmethionine,4TBDMS,isomer #1CSCC[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)N(C(=O)[C@H](C(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C2970.9Standard non polar33892256
Spectra

GC-MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted GC-MSPredicted GC-MS Spectrum - Valylmethionine GC-MS (Non-derivatized) - 70eV, PositiveNot Available2021-10-12Wishart LabView Spectrum

MS/MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Valylmethionine 10V, Positive-QTOFsplash10-0udj-0980000000-094769a697207ff2997f2021-09-22Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Valylmethionine 20V, Positive-QTOFsplash10-0udi-4900000000-7a5fb3f37ca40901a6002021-09-22Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Valylmethionine 40V, Positive-QTOFsplash10-03k9-9100000000-80bbc685b4c44a538bae2021-09-22Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Valylmethionine 10V, Negative-QTOFsplash10-0002-0090000000-d54026a1955dccfb86182021-09-22Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Valylmethionine 20V, Negative-QTOFsplash10-0002-9200000000-98214019143c7c87b3dd2021-09-22Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Valylmethionine 40V, Negative-QTOFsplash10-0002-9000000000-e1d92d2a30bee517d7542021-09-22Wishart LabView Spectrum

NMR Spectra

Spectrum TypeDescriptionDeposition DateSourceView
Predicted 1D NMR1H NMR Spectrum (1D, 100 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 100 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 1000 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 1000 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 200 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 200 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 300 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 300 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 400 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 400 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 500 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 500 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 600 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 600 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 700 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 700 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 800 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 800 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 900 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 900 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Biological Properties
Cellular LocationsNot Available
Biospecimen Locations
  • Feces
Tissue LocationsNot Available
Pathways
Normal Concentrations
BiospecimenStatusValueAgeSexConditionReferenceDetails
FecesDetected but not QuantifiedNot QuantifiedAdult (>18 years old)Both
Normal
details
Abnormal Concentrations
BiospecimenStatusValueAgeSexConditionReferenceDetails
FecesDetected but not QuantifiedNot QuantifiedAdult (>18 years old)Both
Colorectal cancer
details
FecesDetected but not QuantifiedNot QuantifiedAdult (>18 years old)BothColorectal Cancer details
FecesDetected but not QuantifiedNot QuantifiedAdult (>18 years old)Both
Colorectal cancer
details
Associated Disorders and Diseases
Disease References
Colorectal cancer
  1. Brown DG, Rao S, Weir TL, O'Malia J, Bazan M, Brown RJ, Ryan EP: Metabolomics and metabolic pathway networks from human colorectal cancers, adjacent mucosa, and stool. Cancer Metab. 2016 Jun 6;4:11. doi: 10.1186/s40170-016-0151-y. eCollection 2016. [PubMed:27275383 ]
  2. Sinha R, Ahn J, Sampson JN, Shi J, Yu G, Xiong X, Hayes RB, Goedert JJ: Fecal Microbiota, Fecal Metabolome, and Colorectal Cancer Interrelations. PLoS One. 2016 Mar 25;11(3):e0152126. doi: 10.1371/journal.pone.0152126. eCollection 2016. [PubMed:27015276 ]
  3. Goedert JJ, Sampson JN, Moore SC, Xiao Q, Xiong X, Hayes RB, Ahn J, Shi J, Sinha R: Fecal metabolomics: assay performance and association with colorectal cancer. Carcinogenesis. 2014 Sep;35(9):2089-96. doi: 10.1093/carcin/bgu131. Epub 2014 Jul 18. [PubMed:25037050 ]
Associated OMIM IDs
DrugBank IDNot Available
Phenol Explorer Compound IDNot Available
FooDB IDFDB112135
KNApSAcK IDNot Available
Chemspider ID5361146
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkNot Available
METLIN IDNot Available
PubChem Compound6993038
PDB IDNot Available
ChEBI ID75015
Food Biomarker OntologyNot Available
VMH IDNot Available
MarkerDB IDNot Available
Good Scents IDNot Available
References
Synthesis ReferenceNot Available
Material Safety Data Sheet (MSDS)Not Available
General References
  1. Glaser B, Moskvina V, Kirov G, Murphy KC, Williams H, Williams N, Owen MJ, O'Donovan MC: Analysis of ProDH, COMT and ZDHHC8 risk variants does not support individual or interactive effects on schizophrenia susceptibility. Schizophr Res. 2006 Oct;87(1-3):21-7. Epub 2006 Jul 21. [PubMed:16860541 ]
  2. Ishikawa Y, Mukawa J, Kinjo T, Mekaru S, Miyazato H, Takara E, Kuda H: [Crossed cerebellar diaschisis in putaminal hemorrhage--evaluation by the Xe-133 clearance method]. No To Shinkei. 1994 Apr;46(4):335-40. [PubMed:8024832 ]
  3. Brunner EJ, Kivimaki M, Siegrist J, Theorell T, Luukkonen R, Riihimaki H, Vahtera J, Kirjonen J, Leino-Arjas P: Is the effect of work stress on cardiovascular mortality confounded by socioeconomic factors in the Valmet study? J Epidemiol Community Health. 2004 Dec;58(12):1019-20. [PubMed:15547064 ]
  4. Colzato LS, van Muijden J, Band GP, Hommel B: Genetic Modulation of Training and Transfer in Older Adults: BDNF ValMet Polymorphism is Associated with Wider Useful Field of View. Front Psychol. 2011 Sep 1;2:199. doi: 10.3389/fpsyg.2011.00199. eCollection 2011. [PubMed:21909331 ]
  5. Henquet C, Rosa A, Delespaul P, Papiol S, Fananas L, van Os J, Myin-Germeys I: COMT ValMet moderation of cannabis-induced psychosis: a momentary assessment study of 'switching on' hallucinations in the flow of daily life. Acta Psychiatr Scand. 2009 Feb;119(2):156-60. doi: 10.1111/j.1600-0447.2008.01265.x. Epub 2008 Sep 18. [PubMed:18808401 ]
  6. Zhang K, Zheng Z, Gao X, Li J, Zhang F: Possible relationship between the COMT gene ValMet polymorphism and psychometric IQ in girls of the Qinba region in China. Neuropsychobiology. 2007;56(2-3):98-103. doi: 10.1159/000112950. Epub 2008 Jan 10. [PubMed:18182829 ]
  7. Ohta H, Suzuki E, Hinuma Y, Kawamura S, Nemoto M, Hadeishi H: [Effects of hyperoxia, glycerol and ventricular drainage on ICP and CBF in patients with increased ICP due to CSF circulatory-absorbance disturbance]. No To Shinkei. 1987 Mar;39(3):273-9. [PubMed:3580214 ]
  8. Leuchter AF, McCracken JT, Hunter AM, Cook IA, Alpert JE: Monoamine oxidase a and catechol-o-methyltransferase functional polymorphisms and the placebo response in major depressive disorder. J Clin Psychopharmacol. 2009 Aug;29(4):372-7. doi: 10.1097/JCP.0b013e3181ac4aaf. [PubMed:19593178 ]
  9. Ohta H: [The effect of hyperoxemia on cerebral blood flow in normal humans]. No To Shinkei. 1986 Oct;38(10):949-59. [PubMed:3098265 ]
  10. Kuronen P, Sorri MJ, Paakkonen R, Muhli A: Temporary threshold shift in military pilots measured using conventional and extended high-frequency audiometry after one flight. Int J Audiol. 2003 Jan;42(1):29-33. [PubMed:12564513 ]
  11. Ohta H, Nemoto M, Kawamura S, Hadeishi H, Hinuma Y, Suzuki E: [The effects of hyperoxemia on cerebral blood flow in subarachnoid hemorrhage patients]. No To Shinkei. 1987 Jul;39(7):649-56. [PubMed:3118911 ]